134 related articles for article (PubMed ID: 38566456)
1. Contemporary results from the PelvEx collaborative: improvements in surgical outcomes for locally advanced and recurrent rectal cancer.
PelvEx Collaborative
Colorectal Dis; 2024 May; 26(5):926-931. PubMed ID: 38566456
[TBL] [Abstract][Full Text] [Related]
2. Changing outcomes following pelvic exenteration for locally advanced and recurrent rectal cancer.
PelvEx Collaborative
BJS Open; 2019 Aug; 3(4):516-520. PubMed ID: 31388644
[TBL] [Abstract][Full Text] [Related]
3. Pathological determinants of outcome following resection of locally advanced or locally recurrent rectal cancer.
Gould LE; Pring ET; Moorghen M; Burns EM; Antoniou A; Steele CW; Roxburgh CS; Jenkins JT
Eur J Surg Oncol; 2023 Nov; 49(11):106971. PubMed ID: 37442715
[TBL] [Abstract][Full Text] [Related]
4. A systematic review of the pathological determinants of outcome following resection by pelvic exenteration of locally advanced and locally recurrent rectal cancer.
Gould LE; Pring ET; Drami I; Moorghen M; Naghibi M; Jenkins JT; Steele CW; Roxburgh CS
Int J Surg; 2022 Aug; 104():106738. PubMed ID: 35781038
[TBL] [Abstract][Full Text] [Related]
5. Outcomes Following Pelvic Exenteration for Locally Recurrent Rectal Cancer With and Without En Bloc Sacrectomy.
Waller JH; van Kessel CS; Solomon MJ; Lee PJ; Austin KKS; Steffens D
Dis Colon Rectum; 2024 Jun; 67(6):796-804. PubMed ID: 38408876
[TBL] [Abstract][Full Text] [Related]
6. Total pelvic exenteration for locally advanced and locally recurrent rectal cancer in the elderly.
Hagemans JAW; Rothbarth J; Kirkels WJ; Boormans JL; van Meerten E; Nuyttens JJME; Madsen EVE; Verhoef C; Burger JWA
Eur J Surg Oncol; 2018 Oct; 44(10):1548-1554. PubMed ID: 30075979
[TBL] [Abstract][Full Text] [Related]
7. Surgical and Survival Outcomes Following Pelvic Exenteration for Locally Advanced Primary Rectal Cancer: Results From an International Collaboration.
PelvEx Collaborative
Ann Surg; 2019 Feb; 269(2):315-321. PubMed ID: 28938268
[TBL] [Abstract][Full Text] [Related]
8. Minimum radial margin in pelvic exenteration for locally advanced or recurrent rectal cancer.
Aiba T; Uehara K; Tsuyuki Y; Ogura A; Murata Y; Mizuno T; Yamaguchi J; Kokuryo T; Yokoyama Y; Ebata T
Eur J Surg Oncol; 2022 Dec; 48(12):2502-2508. PubMed ID: 35768314
[TBL] [Abstract][Full Text] [Related]
9. Impact of nutritional status and body composition on postoperative outcomes after pelvic exenteration for locally advanced and locally recurrent rectal cancer.
van Rees JM; Visser E; van Vugt JLA; Rothbarth J; Verhoef C; van Verschuer VMT
BJS Open; 2021 Sep; 5(5):. PubMed ID: 34672343
[TBL] [Abstract][Full Text] [Related]
10. [Analysis on risk factors of the degree of radical resection and prognosis of patients with locally recurrent rectal cancer].
Zhang JL; Wu T; Chen GW; Wang PY; Jiang Y; Tang JQ; Wu YC; Pan YS; Liu YC; Wan YL; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):472-479. PubMed ID: 32842427
[No Abstract] [Full Text] [Related]
11. Bladder preservation or complete cystectomy during pelvic exenteration of patients with locally advanced or recurrent rectal cancer, what should we do?
Palma CA; van Kessel CS; Solomon MJ; Leslie S; Jeffery N; Lee PJ; Austin KKS
Eur J Surg Oncol; 2023 Jul; 49(7):1250-1257. PubMed ID: 36658054
[TBL] [Abstract][Full Text] [Related]
12. A 10-year experience of total pelvic exenteration for primary advanced and locally recurrent rectal cancer based on a prospective database.
Nielsen MB; Rasmussen PC; Lindegaard JC; Laurberg S
Colorectal Dis; 2012 Sep; 14(9):1076-83. PubMed ID: 22107085
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of urinary diversion after surgery for locally advanced or locally recurrent rectal cancer with complete cystectomy; ileal and colon conduit.
Hagemans JAW; Voogt ELK; Rothbarth J; Nieuwenhuijzen GAP; Kirkels WJ; Boormans JL; Koldewijn EL; Richardson R; Verhoef C; Rutten HJT; Burger JWA
Eur J Surg Oncol; 2020 Jun; 46(6):1160-1166. PubMed ID: 32122756
[TBL] [Abstract][Full Text] [Related]
14. Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma.
Gannon CJ; Zager JS; Chang GJ; Feig BW; Wood CG; Skibber JM; Rodriguez-Bigas MA
Ann Surg Oncol; 2007 Jun; 14(6):1870-7. PubMed ID: 17406945
[TBL] [Abstract][Full Text] [Related]
15. Image-guided navigation for locally advanced primary and locally recurrent rectal cancer: evaluation of its early cost-effectiveness.
Lindenberg M; Kramer A; Kok E; Retèl V; Beets G; Ruers T; van Harten W
BMC Cancer; 2022 May; 22(1):504. PubMed ID: 35524234
[TBL] [Abstract][Full Text] [Related]
16. Abdominosacral resection: long-term outcome in 86 patients with locally advanced or locally recurrent rectal cancer.
Bosman SJ; Vermeer TA; Dudink RL; de Hingh IH; Nieuwenhuijzen GA; Rutten HJ
Eur J Surg Oncol; 2014 Jun; 40(6):699-705. PubMed ID: 24679359
[TBL] [Abstract][Full Text] [Related]
17. Factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer.
PelvEx Collaborative
Br J Surg; 2018 May; 105(6):650-657. PubMed ID: 29529336
[TBL] [Abstract][Full Text] [Related]
18. A systematic review examining quality of life following pelvic exenteration for locally advanced and recurrent rectal cancer.
Rausa E; Kelly ME; Bonavina L; O'Connell PR; Winter DC
Colorectal Dis; 2017 May; 19(5):430-436. PubMed ID: 28267255
[TBL] [Abstract][Full Text] [Related]
19. What Constitutes a Clear Margin in Patients With Locally Recurrent Rectal Cancer Undergoing Pelvic Exenteration?
Koh CE; Brown KGM; Steffens D; Young J; Salkeld G; Solomon MJ
Ann Surg; 2022 Jan; 275(1):157-165. PubMed ID: 32068551
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous pelvic exenteration and liver resection for primary rectal cancer with synchronous liver metastases: results from the PelvEx Collaborative.
PelvEx Collaborative
Colorectal Dis; 2020 Oct; 22(10):1258-1262. PubMed ID: 32294308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
